In contrast to previous findings that had identified TPC2 overexpression as a potential risk factor for skin cancer, TPCN2 expression was found to be significantly associated with increased survival in bladder cancer (P-value = 3.56E–02). Here, TPCN2 is linked to urinary bladder cancer.